Linezolid and vancomycin, alone and in combination with rifampin, compared with moxifloxacin against a multidrug-resistant and a vancomycin-tolerant Streptococcus pneumoniae strain in an in vitro pharmacodynamic model

被引：11

作者：

Cha, R

Rybak, MJ

机构：

[1] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Antiinfect Res Lab, Dept Pharm Practice, Detroit, MI 48201 USA

[2] Wayne State Univ, Sch Med, Detroit Receiving Hosp, Detroit, MI USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2003年 / 47卷 / 06期

关键词：

D O I：

10.1128/AAC.47.6.1984-1987.2003

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Potential alternatives, including linezolid, adjunctive rifampin, and moxifloxacin, were evaluated against vancomycin-tolerant (P9802-020) and vancomycin-susceptible clinical isolates of Streptococcus pneumoniae in an in vitro pharmacodynamic model. Vancomycin exhibited maximal killing of 2-log(10) CFU/ml against P9802-020. Linezolid, moxifloxacin, and linezolid plus rifampin exhibited 99.9% killing against both isolates. These alternatives should be considered for further evaluation against vancomycin-tolerant S. pneumoniae.

引用

页码：1984 / 1987

页数：4

共 41 条

[31] Comparative In Vitro Activities of First and Second-Generation Ceragenins Alone and in Combination with Antibiotics Against Multidrug-Resistant Klebsiella pneumoniae Strains
Ozbek-Celik, Berna
Damar-Celik, Damla
Mataraci-Kara, Emel
Bozkurt-Guzel, Cagla
Savage, Paul B.
ANTIBIOTICS-BASEL, 2019, 8 (03):
[32] In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model
Akins, RL
Rybak, MJ
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) : 1925 - 1929
[33] Activities of Daptomycin and Vancomycin Alone and in Combination with Rifampin and Gentamicin against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus Isolates in an Experimental Model of Endocarditis
LaPlante, Kerry L.
Woodmansee, Suzanne
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (09) : 3880 - 3886
[34] Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model
Snyder, Ashley Hall
Werth, Brian J.
Barber, Katie E.
Sakoulas, George
Rybak, Michael J.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (08) : 2148 - 2154
[35] Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model
DarrasJoly, C
Bedos, JP
Sauve, C
Moine, P
Vallee, E
Carbon, C
AzoulayDupuis, E
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (09) : 2147 - 2151
[36] Killing activities of trovafloxacin alone and in combination with β-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically achievable in cerebrospinal fluid
Fitoussi, F
Doit, C
Geslin, P
Bingen, E
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (10) : 2372 - 2375
[37] Evaluation of Standard- and High-Dose Daptomycin versus Linezolid against Vancomycin-Resistant Enterococcus Isolates in an In Vitro Pharmacokinetic/Pharmacodynamic Model with Simulated Endocardial Vegetations
Hall, Ashley D.
Steed, Molly E.
Arias, Cesar A.
Murray, Barbara E.
Rybak, Michael J.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (06) : 3174 - 3180
[38] Activity of Vancomycin and Piperacillin-Tazobactam in combination against Methicillin-Resistant Staphylococcus aureus and VAN-intermediate Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic infection model.
Dilworth, Tom
Leonard, Steve
Mercier, Renee
PHARMACOTHERAPY, 2013, 33 (10): : E215 - E216
[39] Treatment of vancomycin-resistant Enterococcus faecium with RP 59500 (quinupristin-dalfopristin) administered by intermittent or continuous infusion, alone or in combination with doxycycline, in an in vitro pharmacodynamic infection model with simulated endocardial vegetations
Aeschlimann, JR
Zervos, MJ
Rybak, MJ
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) : 2710 - 2717
[40] Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model
Houlihan, HH
Mercier, RC
Rybak, MJ
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) : 2497 - 2501

← 1 2 3 4 5 →